ici 204,219 has been researched along with pulmicort in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Grum, CM | 1 |
| Calişir, HC; Ogretensoy, M; Tunçtan, B; Yurdakul, AS | 1 |
| Huang, HY; Lee, YC; Perng, DW; Perng, RP | 1 |
| Aydemir, A; Cakmak, G; Demir, T; Donma, O; Gemicioglu, B; Serdaroglu, E | 1 |
| Boushey, HA; Chinchilli, VM; Craig, TJ; Deykin, A; Dimango, EA; Fagan, JK; Fahy, JV; Fish, JE; Ford, JG; Israel, E; King, TS; Kraft, M; Lazarus, SC; Lemanske, RF; Leone, FT; Martin, RJ; Mauger, EA; Pesola, GR; Peters, SP; Rollings, NJ; Sorkness, CA; Sullivan, SD; Szefler, SJ; Wechsler, ME | 1 |
| Fabbri, LM | 1 |
| Chowdhury, BA | 1 |
| Boushey, HA | 1 |
| Deykin, A; Finn, PW; Gibbons, FK; He, HZ; Israel, E; Perkins, DL; Schaub, B | 1 |
| Antoniu, SA | 1 |
| Carrasco, JL; Chinchilli, VM; King, TS; Wang, KL | 1 |
1 review(s) available for ici 204,219 and pulmicort
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for ici 204,219 and pulmicort
| Article | Year |
|---|---|
Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.
Topics: Adrenergic beta-Agonists; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Phosphodiesterase Inhibitors; Respiratory Mechanics; Sulfonamides; Theophylline; Tosyl Compounds | 2002 |
Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Asthma; Budesonide; Female; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Severity of Illness Index; Sulfonamides; Tosyl Compounds | 2004 |
The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients.
Topics: Adolescent; Adult; Antioxidants; Asthma; Bronchial Hyperreactivity; Bronchodilator Agents; Budesonide; Double-Blind Method; Drug Therapy, Combination; Eosinophil Cationic Protein; Female; Humans; Indoles; Leukotriene Antagonists; Male; Middle Aged; Phenylcarbamates; Placebos; Respiratory Function Tests; Sulfonamides; Tosyl Compounds | 2004 |
Daily versus as-needed corticosteroids for mild persistent asthma.
Topics: Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adult; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Indoles; Male; Peak Expiratory Flow Rate; Phenylcarbamates; Sulfonamides; Tosyl Compounds | 2005 |
The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13 and IFN-gamma secretion.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Budesonide; Drug Therapy, Combination; Female; Glucocorticoids; Glycoproteins; Humans; Indoles; Interferon-gamma; Interleukin-13; Leukocytes, Mononuclear; Leukotriene Antagonists; Lymphocyte Activation; Male; Middle Aged; Phenylcarbamates; Phytohemagglutinins; Prednisone; Sulfonamides; Tosyl Compounds | 2005 |
11 other study(ies) available for ici 204,219 and pulmicort
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Disturbing asthma statistics reflect suboptimal management.
Topics: Adrenergic beta-Agonists; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Budesonide; Humans; Immunotherapy; Indoles; Leukotriene Antagonists; Phenylcarbamates; Pregnenediones; Sulfonamides; Terbutaline; Tosyl Compounds; United States | 1997 |
The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).
Topics: Abnormalities, Drug-Induced; Acetates; Administration, Inhalation; Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Asthma; Budesonide; Chlorpheniramine; Cyclopropanes; Ephedrine; Female; Histamine H1 Antagonists; Humans; Hydroxyurea; Hypersensitivity; Indoles; Ipratropium; Leukotriene Antagonists; Metaproterenol; Nasal Decongestants; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Terbutaline; Tosyl Compounds; Tripelennamine | 2000 |
Does mild persistent asthma require regular treatment?
Topics: Administration, Inhalation; Administration, Oral; Anti-Asthmatic Agents; Asthma; Budesonide; Drug Administration Schedule; Humans; Indoles; Phenylcarbamates; Sulfonamides; Tosyl Compounds | 2005 |
Treatment of mild asthma.
Topics: Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Budesonide; Drug Administration Schedule; Forced Expiratory Volume; Humans; Indoles; Peak Expiratory Flow Rate; Phenylcarbamates; Research Design; Sulfonamides; Tosyl Compounds | 2005 |
Daily inhaled corticosteroid treatment should not be prescribed for mild persistent asthma. Con.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Asthma; Bronchodilator Agents; Budesonide; Clinical Trials as Topic; Drug Administration Schedule; Humans; Indoles; Leukotriene Antagonists; Phenylcarbamates; Sulfonamides; Tosyl Compounds | 2005 |
Daily versus intermittent corticosteroids for the treatment of mild persistent asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Asthma; Budesonide; Drug Administration Schedule; Glucocorticoids; Humans; Indoles; Leukotriene Antagonists; Middle Aged; Phenylcarbamates; Randomized Controlled Trials as Topic; Sulfonamides; Tosyl Compounds | 2006 |
A class of repeated measures concordance correlation coefficients.
Topics: Absorptiometry, Photon; Adolescent; Adrenal Cortex Hormones; Algorithms; Anti-Asthmatic Agents; Asthma; Biometry; Blood Chemical Analysis; Budesonide; Child; Computer Simulation; Controlled Clinical Trials as Topic; Diagnostic Techniques and Procedures; Female; Humans; Hydrocortisone; Indoles; Models, Statistical; Monte Carlo Method; Observer Variation; Phenylcarbamates; Reproducibility of Results; Sulfonamides; Tosyl Compounds; Treatment Outcome | 2007 |